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Glycosyl-phosphatidylinositol molecules, acting as both signal transduction elements and membrane protein anchors,
have been proposed to play a role during T-cell activation. The MVB2 cell line is a mutant, derived from the wild-type
T-T hybrid YH.16.33, which has a defect in the biosynthesis of Ptdlns-protein linkages. As a consequence, MVB2
mutants are defective in activation through the T-cell receptor. Despite the lack of glycosyl-Ptdlns anchors in the mutant
MVB2 cells, a comparison of the levels and structural features of the insulin-sensitive glycosyl-Ptdlns between the MVB2
and YH. 16.33 lineages indicates that both cell lines are identical in this respect. The time course for insulin-responsiveness
coincides in both cell lines, with maximal hydrolysis 30 s after insulin addition. The ultimate localization of insulin-
regulated glycosyl-Ptdlns at the outer surface of the cell membrane is also similar. These data indicate that the glycosyl-
Ptdlns whose hydrolysis is regulated by insulin is not anchoring proteins at the cell surface of T-lymphocytes.
INTRODUCTION
Glycosyl-phosphatidylinositol molecules display important
dual functions in eukaryotic cells, as membrane anchors of
covalently attached proteins [1,2] and as precursors to the inositol
phospho-oligosaccharide (IPG), a putative mediator of insulin
action [3,4]. A variety of proteins which play a role during T-cell
activation are anchored to the cell surface by a glycosyl-Ptdlns
linkage, e.g. the T-cell-activating protein (TAP), Thy- 1 and other
Ly-6 proteins [5]. MVB2 cells are mutant T-lymphocyte clones
with defects in the assembly of glycosyl-Ptdlns-TAP. This
mutation greatly affects the immune responsiveness of these
clones when compared with the parental line YH. 16.33. These
results strongly support a role for glycoproteins linked through
a glycosyl-Ptdlns anchor to the cell surface in physiological T-
cell activation [6,7]. The anchorage functions are not yet fully
understood, but these molecules may transmit activation signals,
and their physiological functions may thus involve membrane
interactions in addition to those of protein attachment to the
bilayer. In this context, it has been proposed that glycosyl-Ptdlns
linkages are also the precursor molecules of IPG [8]. In this
model, insulin would stimulate a Ptdlns-specific phospholipase C
(Ptdlns-PLC) and a proteinase, with liberation of protein, IPG
and diacylglycerol, all of which will serve a different biological
function. This hypothesis is questioned, however, by the finding
that these glycosyl-Ptdlns molecules may exhibit different chemi-
cal compositions [1,9], and definitive data supporting such
regulation have not been reported.
The insulin receptor, together with interleukin-2 and trans-
ferrin receptors, is one of a group of early response genes that are
expressed following mitogen or antigen stimulation of T-lympho-
cytes [10]. The binding of each of these growth factors is essential
for optimal T-cell proliferation, and even for cellular differen-
tiation. A role for glycosyl-Ptdlns molecules as precursors to
insulin and interleukin-2 signal transduction elements in lympho-
cytes has been recently proposed [11-13].
In this paper we present the chemical composition, biosynthesis
and final localization of insulin-regulated glycosyl-Ptdlns in T-
lymphocyte mutant clones with defects in the synthesis of the
Ptdlns-protein linkage. Our results indicate that both the mutant
and parental lines are able to synthesize an insulin-sensitive
glycosyl-PtdIns and to target it to the plasma membrane. This
molecule fulfils the structural features reported for the glycosyl-
Ptdlns involved in the insulin signalling pathway. Furthermore,
IPG purified from both YH.16.33 and MVB2 cells exhibited
biological activity in vitro. These findings help us to ascertain the
role of the distinct glycosyl-Ptdlns molecules during T-cell
activation, and indicate that the different functions described for
them are achieved by specific members of the glycosyl-Ptdlns
family.
MATERIALS AND METHODS
Radioactive substrates
[6-3H]Glucosamine (32 Ci/mmol), myo-[2-3H]inositol (19 Ci/
mmol), [1_-3H]ethan- 1-ol-2-amine (19 Ci/mmol), [methyl-3H]-
choline chloride (78.2 Ci/mmol) and [3-3H]serine (30 Ci/mmol)
were from Amersham. [1-3H(n)]galactose (21.7 Ci/mmol), [9,10-
3H]myristic acid (22.4 Ci/mmol), [9,10-3H]palmitic acid
(28.5 Ci/mmol) and [5,6,8,9,11,12,14,1 5-3H]arachidonic acid
(238 Ci/mmol) were from New England Nuclear.
Cell culture
The mouse T-T hybridoma YH.16.33 (wild-type hybrid) and
the glycosyl-Ptdlns-protein-linkage deficient mutant MVB2 cell
lines were a gift from Dr. K. L. Rock (Harvard Medical School,
Boston, MA, U.S.A.) [6]. Cells were grown in Dulbecco's
modified Eagle's medium containing 10 ° fetal calf serum,
2mM-L-glutamine, 100 units of penicillin/ml and 100,ug of
streptomycin/ml at 37°C in air/CO2 (19:1). Culture medium
and additives were from Flow Laboratories. Cultures were
typically seeded at I x 105/ml and grown for 48 h to densities of
approx. 1 x 106/ml. Before use, lymphocytes were harvested by
centrifugation (1000 g for 6 min), washed twice and resuspended
in 5 mM-sodium phosphate, pH 7.4, containing 150 mM-NaCl.
The integrity of cells was measured by the Trypan Blue exclusion
test, and in all experiments was at least 90 °,/ .
Cell labelling and glycosyl-Ptdlns purification
Cells in exponential growth phase were labelled for 24 h in the
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Fig. 1. Labelling of cells with I3Hlglucosamine
YH. 16.33 (a, b) and MVB2 (c, d) cells were labelled for 24 h with [3H]glucosamine, and the [3H]glycosyl-Ptdlns was purified by three sequential
t.l.c. steps as described in the Materials and methods section. (a) and (c), first t.l.c. step, developed in an acidic solvent system; (b) and (d), second
t.l.c. step, developed in a basic solvent system. After each chromatography, 1 cm sample fractions were scraped off and the radioactivity associated
with each sample was determined by scintillation counting. The positions of marker phospholipid are indicated: Gly-PtdIns, glycosyl-Ptdlns;
PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; NL, neutral lipids, PtdOH, phosphatidic acid; SF, solvent front.
presence of the various labels at 5 ,uCi/ml, except for [3H]serine
(2 ,uCi/ml), and myo-[3H]inositol (10 zCi/ml). At the end of the
incubation period cells were collected, resuspended in 2 ml of
phosphate/saline buffer and 2 ml of ice-cold 10 %/ trichloroacetic
acid was added to each sample. After standing for 15 min at
4°C, cellular lipids were extracted and glycosyl-Ptdlns was
purified as indicated in [9]. Briefly, the trichloroacetic acid
treatment was followed by a low-speed centrifugation, the pellets
were extracted with 1.5 ml of chloroform/methanol (1:2, v/v)
containing 0.05 M-HCI. After standing for 15 min at room
temperature, the sample was centrifuged (1500 g, 5 min) and the
supernatant transferred to a clean tube. The pellet was re-
extracted with 0.75 ml of chloroform/methanol (1:2, v/v)/
0.05 M-HCI, centrifuged as above and the supernatants pooled.
Chloroform (0.75 ml) plus 0.1 M-KCI (0.75 ml) were added and
the organic and aqueous phases were separated by centrifugation
(1500 g, 5 min) at 4 'C. The aqueous phases were treated with
0.75 ml of chloroform and again centrifuged; then the organic
phases were pooled. Finally, 0.75 ml of 0.1 M-KCI in 50 °
methanol was added to the organic phases; after standing at
-20 'C for 30 min, the organic phases were collected and
evaporated to dryness in a Speed-svac concentrator. The dried
samples were dissolved into 50 ,ul of chloroform/methanol (2: 1,
v/v) and spotted on to a silica Gel G60 TLC (Merck) plate. The
plate was developed twice with chloroform/acetone/methanol/
glacial acetic acid/water (10:4:2:2:1, by vol.), and the material
which remained at the origin of the plate (0.5 cm below to 2 cm
above the origin) was scraped off and extracted three times with
I ml ofmethanol at 37 'C. The acidic plate extract was evaporated
as above and loaded on to a second silica Gel G plate, which
was developed once in chloroform/methanol/NH40H/water
(45:45:4: 10, by vol.). Regions of I cm were scraped and assayed
for radioactivity in a Beckman f-scintillation counter. In some
instances, indicated in the text, labelled glycosyl-Ptdlns peaks
from either the acidic or basic plates were spotted on silica Gel
G plates and a two-dimensional chromatography was carried
out. Plates were developed first in chloroform/methanol/water
(10:10: 3, by vol.) and secondly in chloroform/methanol/
NH40H/water (90:90:7:20, by vol.). Radioactivity associated
with glycosyl-Ptdlns was evaluated by fluorography after spray-
ing the plates with En3Hance (New England Nuclear). Verifi-
cation ofthe integrity ofmetabolic labels in sugars was established
by acid hydrolysis of lipids in 4 M-HCI at 110 'C for 5 h, followed
by t.l.c. analysis of free sugars in pyridine/ethyl acetate/glacial
acetic acid/water (5:5:1:3, by vol.).
Glycosyl-Ptdlns characterization
To determine the nitrous acid sensitivity of the glycolipids,
samples of purified [3H]glycophospholipid obtained from each
cell line by metabolic labelling with [3H]glucosamine for 24 h
were treated with nitrous acid as described elsewhere [14,15].
Sensitivity to Ptdlns-PLC was assessed using a commercial
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Ptdlns-PLC purified from Bacillus cereus (Boehringer-Mann-
hein) or Ptdlns-PLC from Bacillus thuringiensis (strain 11607).
Ptdlns-PLC from B. thuringiensis was generously provided by
donation of Dr. S. Udenfriend (Hoffman-LaRoche, Nutley, NJ,
U.S.A.). A sample of purified labelled glycolipid was resuspended
in 0.2 ml of 20 mM-sodium borate, pH 7.4, containing 0.1600
(w/v) sodium deoxycholate. Glycosyl-Ptdlns was dissolved in
detergent-containing buffer by ultrasonication (3 x 1 min) and
treated with 1 unit of either Ptdlns-PLC for 2 h at 37 °C [9,14,15].
Reactions were terminated by the addition of chloroform/
methanol (1: 2, v/v)/0.05 M-HCI, and the amount of [3H]glycosyl-
Ptdlns remaining was determined.
Glycosyl-Ptdlns localization
MVB2 and YH.16.33 cells were labelled as above with 10 ,uCi
of [3H]galactose/ml and then treated with 8-galactosidase from
Escherichia coli (Sigma, St. Louis, MO, U.S.A.) (25 units/ml) for
90 min at 37 °C, as in [14]. Similar treatment was carried out with
6 units of Ptdlns-PLC/ml from B. thuringiensis in cells labelled
with [3H]glucosamine. One unit of Ptdlns-PLC activity is defined
as the amount of enzyme that hydrolyses I ,umol of Ptdlns in
1 min at 37 'C. After these treatments, glycosyl-Ptdlns was
purified as described above.
acid and phosphatidylcholine standards and its separation from
phosphatidylinositol 4,5-biphosphate and phosphatidylinositol
4-phosphate, which are the major known contaminants after
chromatography in the first solvent system, was satisfactory. The
amount of 3H-labelled peak III recovered was identical when
cells were labelled for 24, 36 or 48 h (results not shown). Peak III
co-migrated with authentic insulin-sensitive [3H]glycosyl-Ptdlns
standard, which was prepared as described in [I 1] from isolated
rat hepatocytes. The chromatographic patterns obtained with
the two cell lines were identical. The average amount of radio-
activity incorporated into peak II was 546 + 84 d.p.m./106 cells
in MVB2 cells and 611 + 82 d.p.m./106 cells in YH.16.33 cells.
Further analysis of glucosamine-labelled peak III from either
cell line was achieved by its elution from the silica and application
to a third thin layer plate for two-dimensional chromatography,
followed by fluorographic detection of the labelled glycosyl-
Ptdlns. As shown in Figs. 2(a) and 2(b), a single spot was
apparent, indicating that under these conditions [3H]glucos-
amine-labelled peak III is homogenous and comparable in
YH.16.33 (Fig. 2a) and MVB2 (Fig. 2b) cells.
Chemical characterization of glycosyl-Ptdlns
Comparison of the structures of glycosyl-Ptdlns linkages so
Evaluation of insulin binding
Insulin binding by MVB2 and YH.16.33 cells (1 x 106 cells per
assay) was determined at 15 °C for 1 h using '25l-insulin as
described in [11]; the insulin concentration in the assay was
82,tM. Mono-'251-insulin with a specific radioactivity of 240-
300 ,tCi/,ug was prepared as in [16].
Biosynthetic labelling of glycosyl-Ptdlns-anchored proteins
Metabolic labelling of T-T hybridomas with [3H]glucosamine
or [3H]palmitic acid was performed as previously described [6].
3H-labelled proteins were analysed by SDS/PAGE (180% gels)
under reducing conditions. Gels were then fixed, soaked for
30 min in Amplify (Amersham) and dried, and the proteins were
visualized by fluorography. All electrophoretic reagents were
from Bio-Rad.
RESULTS AND DISCUSSION
Incorporation of [3Hlglucosamine into YH.16.33 and MVB2 cell
lipids
Both cell lines were labelled to equilibrium with [3H]-
glucosamine for 24 h. Glucosamine has been shown to be
incorporated into all glycosyl-Ptdlns molecules described so far.
After labelling, lipids were extracted and analysed by t.I.c. as
already described. Labelling of YH.16.33 and MVB2 cells is
shown in Figs. 1(a) and l(c) respectively. In both cases a major
peak, peak I, was detected at the origin of the acid solvent plate
which co-migrated with [3H]glycosyl-Ptdlns purified from rat
liver.
Peak I was eluted from the silica and spotted on to a second
t.l.c. plate, which was developed in a basic solvent system as
shown in Figs. l(b) (wild-type) and l(d) (mutant). Under these
conditions peak I was resolved into two distinct peaks, II and III.
Peak II co-migrated with the phosphatidylinositol 4-phosphate
standard, and its sensitivity to nitrous acid cleavage was low
(9.65 0/o and 13.7 0/o cleavage in YH.16.33 and MVB2 cells
respectively). The migration of peak III relative to peak II was
maintained, and this peak migrated between the phosphatidic
,:PtdEtn
.PtdOH
PtdCho
(a)
4
, PtdEtn
X. -, PtdOH
PtdCho.
--- .
- S
Or
( b)
2
2 Or
Fig. 2. Two-dimensional t.l.c. of 13Hjglucosamine-labelled peak III
Samples of peak III from YH.16.33 (a) and MVB2 (b) cells were
eluted from the second t.l.c. step and spotted at one corner (Or) of
the plates. The chromatogram was developed in the first solvent (1),
dried briefly, turned through 900 and developed in the second
solvent (2); finally, the plate was dried and labelled glycosyl-Ptdlns
detected by fluorography of the plate. Phospholipid standards were
visualized with 12 and are indicated by dotted lines: PtdEtn,
phosphatidylethanolamine; PtdCho, phosphatidylcholine; PtdOH,
phosphatidic acid.
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Table 1. Metabolic labelling of peak III glycosyl-Ptdlns
YH. 16.33 and MVB2 cells were labelled with the various precursors
for 24 h as described in the Materials and methods section. At the
end of this period, cell lipids were extracted and peak III was
purified by sequential t.l.c. as described in the legend to Fig. 1. The
incorporation of the different labels into peak III was determined by
scintillation counting. In the upper panel, the amount of radio-
activity present in peak III of cells labelled with [3H]myristic acid
(16860d.p.m./106 MVB2 cells and 18217d.p.m./106 YH.16.33
cells) was given the arbitrary value of 100 %. In the lower panel, the
amount of radioactivity incorporated into peak III of cells labelled
with [3H]glucosamine (883 d.p.m./106 MVB2 cells and
981 d.p.m./106 YH.16.33 cells) was given the arbitrary value of
100 %. Results are the means of at least three different experiments.
Relative incorporation (0/o)
Labelled precursor YH.16.33 MVB2
Myristic acid
Palmitic acid
Arachidonic acid
Glucosamine
Galactose
Mannose
myo-Inositol
Serine
Ethanolamine
Choline
100
21
5
100
197
5
7
5
5
5
100
37
5
100
299
5
16
5
5
5
far elucidated indicates a strict conservation of a phosphatidyl-
inositol-glucosamine-(mannose)3-phosphoethanolamine core
among them [17,18]. Rat brain Thy-I anchor has an extra
phosphoethanolamine and several additional mannosyl residues
[19]. Different chemical compositions of insulin-sensitive
glycosyl-Ptdlns and IPG have been reported [20-22]. In H35 cells
and rat liver membranes a compound has been described which
contains phospho-chiro-inositol linked glycosidically to one
glucosaminyl and several additional galactosyl residues [21].
Analysis of the chemical composition of glucosamine-con-
taining peak III was performed by metabolic labelling. YH. 16.33
and MVB2 cells (1 x 105) were labelled by a 24 h incubation with
the various precursors, and at the end of this period lipids were
extracted and peak III was purified using the acid/base t.l.c.
system described in Fig. 1. A comparison between the quantities
of 3H-labelled peak III recovered after labelling of the cells for 24
or 48 h indicated that the labelling with the various precursors
was at equilibrium after 24 h. In all experiments, control cells
were labelled with [3H]glucosamine and the [3H]glucosamine-
labelled peak III was purified in parallel with the samples
containing the other labels. As shown in Table 1, selectivity of
fatty acid incorporation was observed. The highest incorporation
was obtained with myristic acid (C14:0), followed by palmitic acid
(C16: 0). Little label was recovered when arachidonic acid (C20:4)
was used. There were no significant differences in the degree of
incorporation between the mutant MVB2 and the wild-type
YH.16.33 cells. The heterogeneous fatty acid composition of the
glycosyl-PtdIns purified from T-T hybrids agrees with that
reported for T-lymphocytes [11]. However, this is in contrast
with results from other cell lines and sources [9,20,21].
As also shown in Table 1, YH.16.33 and MVB2 cells were also
labelled with myo-inositol, serine, ethanolamine, choline, gal-
actose and mannose. Ethanolamine, inositol and mannose are
known to be components of the glycosyl-Ptdlns anchor [18,19].
No significant incorporation of any of the above labels was
detected in purified peak III, with the exception of galactose.
Verification of the integrity of metabolic labels in sugars was
achieved by acid hydrolysis of lipids and t.l.c. analysis. In each
instance, more than 95% of the label was recovered in the
original source. As observed when fatty acid incorporation
was studied, no significant differences were obtained between
YH.16.33 and MVB2 cells.
Under the same conditions, metabolic labelling of glycosyl-
Ptdlns protein molecules with [3H]glucosamine or [3H]palmitic
acid was carried out. 3H-labelled glycosyl-Ptdlns-proteins were
analysed on 180% SDS/PAGE gels and then visualized by
fluorography. In agreement with previous data [6], YH. 16.33 but
not MVB2 cells were able to incorporate both radioactive
precursors into proteins with the same molecular masses as TAP
and Thy-I (results not shown).
The synthesis of the major structural phospholipids was also
studied in the two cell lines. A good incorporation of choline into
phosphatidylcholine, ethanolamine into phosphatidylethanol-
amine and serine into phosphatidylserine was observed under the
conditions of labelling, indicating that the precursors were
entering the cells. The ratio of choline incorporation into
PtdChol/glucosamine incorporation into glycosyl-Ptdlns was
118.9 in YH.16.33 cells and 117.7 in the mutant MVB2 cell line.
Similar ratios between the two cell lines were found when serine
or ethanolamine incorporation into their respective phospho-
lipids was compared with glucosamine or palmitic acid incorpor-
ation into glycosyl-Ptdlns, indicating that MVB2 cells do
not show significant alterations in phospholipid metabolism.
To further characterize peak III, its sensitivity to nitrous acid
deamination and to Ptdlns-PLC was tested in cells pre-labelled
with [3H]glucosamine for 24 h as described in [8]. Phospholipase
treatment was carried out using either B. cereus or B. thuringiensis
Ptdlns-PLC, for 2 h at 37 'C. The amount of [3H]glycosyl-Ptdlns
recovered over the total period was about 24% and 650
respectively. These data suggest that the glycosyl-Ptdlns re-
covered in peak III might be heterogeneous, despite the fact that
it migrates as a single peak in one- and two-dimensional t.l.c. No
differences were observed in glycosyl-Ptdlns sensitivity to
phospholipase between the wild-type and the mutant cells. These
results indicate that peak III glycolipid contains Ptdlns, despite
the failure to find myo-inositol labelling under conditions where
other precursors were incorporated. This discrepancy may be
explained by the presence of different inositol isomers in peak III,
as has been described in H35 hepatoma cells and rat liver
membranes [21,22]. Nitrous acid treatment indicted that peak III
purified from either cell line was cleaved by about 200%. The
glycosyl-PtdIns sensitivity to acid deamination previously re-
ported varied greatly among the sources used [9,11,12].
In conclusion, glycosyl-PtdIns purified from MVB2 cells has
all the same characteristics as the lipid purified from YH. 16.33
that we have been able to assay for.
Localization of glycosyl-Ptdlns at the plasma membrane
TAP and Thy-1 molecules are absent from the cell surface of
MVB2 mutants, but there is a normal expression of other T-cell
surface proteins [6]. MVB2 cells synthesize low-molecular-mass
forms of TAP and Thy-1 proteins which lack the lipid moiety
present on the membrane forms of the corresponding wild-type
proteins. Insulin-sensitive glycosyl-Ptdlns has been localized at
the outer surface of human lymphocytes by a combination of
chemical labelling and enzymic modifications with ,J-galactos-
idase and Ptdlns-PLC [14].
A similar approach was used to study whether the final
localization of glycosyl-Ptdlns was affected in MVB2 mutants.
Metabolically labelled MVB2 and YH.16.33 cells (1 x 101 cells)
were treated with ,J-galactosidase or Ptdlns-PLC. The amounts
1992
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of 3H-labelled glycosyl-Ptdlns purified from 1 x 106 YH.16.33
and MVB2 cells after incubation with ,-galactosidase were
73.1 % (n = 3) and 72% (n = 4) respectively of that isolated
from control cells. These percentages are lower than those found
in rat hepatocytes [14], indicating heterogeneity among different
cell types. Also, they suggest heterogeneity within the glycosyl-
Ptdlns molecules exposed at the cell surface.
In cells treated with Ptdlns-PLC from B. thuringiensis, the
amount of [3H]glucosamine-labelled glycosyl-PtdIns was 56% in
YH.16.33 cells (n = 3) and 49% in MVB2 cells (n = 4) of that
recovered from control cells. Therefore we conclude that both
cell lines have an analogous distribution of glycosyl-PtdIns
molecules at the plasma membrane. Furthermore, the data
obtained with Ptdlns-PLC treatment indicate that both wild-
type and mutant cells are able to efficiently target glycosyl-PtdIns
molecules to the cell surface, despite the absence of Ptdlns-
anchored proteins in MVB2 cells. The different degrees of
hydrolysis observed between the two enzymic treatments further
confirm the existence of uncomplexed glycosyl-Ptdlns subtypes
in T-T hybrids which may have distinct functional roles. Similar
results have been obtained in T- and B-lymphocytes [11,12].
The question addressed here is: do changes in the biosynthetic
pathway of glycosyl-Ptdlns anchors caused by a mutation affect
the levels or turnover regulation of the glycolipid implicated in
insulin function? The data presented above clearly demonstrate
that glycosyl-Ptdlns levels, their structural features and ultimate
localization in MVB2 and YH. 16.33 cells are identical. Conse-
quently, we studied whether insulin is able to differentially affect
the turnover of peak III glycosyl-Ptdlns.
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Fig. 3. Effect of insulin on the turnover of glycosyl-Ptdlns
YH.16.33 (0) and MVB2 (A) cells were incubated with [3H]-
glucosamine for 24 h. Cells were washed and incubated for 90 min
in serum-free medium at a concentration of 5 x 106/ml. Cells were
treated with insulin (1 nM) for the different periods of time. Reactions
were terminated by addition of an equal volume of cold 20%
trichloroacetic acid and lipids were extracted as described in the
Materials and methods section. Levels of [3HJglycosyl-Ptdlns were
determined by scintillation counting of t.l.c.-purified lipids. Results
are the mean + S.E.M. of at least six independent experiments.
Insulin-dependent glycosyl-Ptdlns hydrolysis in YH.16.33 and
MVB2 cells
Both types of cells bound similar amounts of 1251-insulin, i.e.
740+ 91 and 689+ 102 c.p.m./106 cells (n = 8) for the wild-type
and mutant respectively. Basal levels of labelled glycosyl-Ptdlns
were also identical, as shown in Fig. 1. The analogous in-
corporation of [3H]glucosamine into glycosyl-Ptdlns in both cell
lines indicates that glycosyl-Ptdlns turnover is comparable be-
tween the parental line and the anchorage mutant. Previous
studies have indicated a correlation between the levels of glycosyl-
Ptdlns and those of insulin receptors in various cell types [23,24],
including T-lymphocytes [11].
To determine the effect of insulin on glycosyl-Ptdlns hydrolysis,
1 X 105 YH.16.33 and MVB2 cells were labelled with [3H]-
glucosamine for 24 h to achieve steady-state labelling of glycosyl-
Ptdlns. Cells were then washed into insulin-free medium for
90 min, after which reactions were initiated by the addition of
1 nM-insulin. Incubations were carried out for the times indicated
in Fig. 3, and glycosyl-Ptdlns levels were determined. The
addition of insulin to T-T hybrid wild-type cells led to the loss of
about 54% of the glycosyl-Ptdlns within 30 s. The MVB2 cells
responded by hydrolysing 61 % of the glycolipid, with the same
fast and reversible time course (Fig. 3). Resynthesis of glycosyl-
Ptdlns began rapidly thereafter, and by 4-5 min levels had
reached a new steady-state value. The same results were obtained
in cells labelled with either [3H]palmitate or [3H]galactose (results
not shown). These data indicate that insulin is a potent regulator
of glycosyl-Ptdlns turnover in both YH.16.33 and MVB2 cells.
Biological activity of IPG
Insulin-dependent hydrolysis of glycosyl-Ptdlns by Ptdlns-
PLC liberates its polar head group, IPG, which displays a variety
of insulin-like actions and has been proposed as a mediator of
insulin action (for reviews see [3] and [25]). The biological
Vol. 282
activity of IPG from T-T hybrid cells was assessed in vitro by
testing its capacity to inhibit the phosphorylation of histone IIA
by the cyclic AMP-dependent protein kinase, as described
previously [26]. IPG was prepared by hydrolysis with bacterial
PtdIns-PLC of glycosyl-Ptdlns purified from either YH.16.33 or
MVB2 cells (1 x 108 cells) as in [15]. The concentration of IPG
was calculated by measuring free amino groups, assuming that
each molecule of IPG contains one amino group [14]. The
addition of IPG (10 /uM), purified from YH. 16.33 or MVB2 cells,
to the protein kinase A assay caused respectively 76% and 83 %
inhibition of the kinase activity over 10 min. The incorporation of
32P into washed histone IIA in control samples was about
41000 c.p.m., and the experiment was performed twice in dupli-
cate. These data indicate that both the Ptdlns-anchor-deficient
mutant and the wild-type T-T hybrid possess a fully active IPG.
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